I.M. Ambros

1.7k total citations
17 papers, 1.2k citations indexed

About

I.M. Ambros is a scholar working on Neurology, Molecular Biology and Epidemiology. According to data from OpenAlex, I.M. Ambros has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 8 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in I.M. Ambros's work include Neuroblastoma Research and Treatments (12 papers), Cancer therapeutics and mechanisms (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). I.M. Ambros is often cited by papers focused on Neuroblastoma Research and Treatments (12 papers), Cancer therapeutics and mechanisms (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). I.M. Ambros collaborates with scholars based in Austria, United States and Germany. I.M. Ambros's co-authors include Peter F. Ambros, Junichi Hata, V V Joshi, Louis P. Dehner, Hiroyuki Shimada, Borghild Roald, Sabine Strehl, Heinrich Kovar, Michael Dworzak and H. Gadner and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and British Journal of Cancer.

In The Last Decade

I.M. Ambros

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I.M. Ambros Austria	14	852	472	334	209	191	17	1.2k
Cynthia Winter United States	12	928 1.1×	808 1.7×	536 1.6×	81 0.4×	83 0.4×	15	1.3k
Frida Abel Sweden	18	383 0.4×	419 0.9×	315 0.9×	75 0.4×	114 0.6×	27	736
Delphine Lequin France	6	717 0.8×	618 1.3×	370 1.1×	147 0.7×	38 0.2×	10	1.0k
Cynthia S. Kretschmar United States	21	864 1.0×	490 1.0×	216 0.6×	339 1.6×	236 1.2×	30	1.4k
Brodeur Gm United States	11	841 1.0×	464 1.0×	310 0.9×	50 0.2×	93 0.5×	19	939
S. Pinson France	19	399 0.5×	205 0.4×	139 0.4×	254 1.2×	242 1.3×	39	1.1k
Maria Łastowska United Kingdom	20	1.2k 1.4×	925 2.0×	483 1.4×	87 0.4×	69 0.4×	40	1.6k
Naomi L. Bowers United Kingdom	21	729 0.9×	557 1.2×	172 0.5×	172 0.8×	76 0.4×	38	1.4k
Takahiro Gotoh Japan	17	345 0.4×	710 1.5×	308 0.9×	360 1.7×	58 0.3×	27	1.2k
M. Eva Alonso Spain	22	257 0.3×	683 1.4×	192 0.6×	85 0.4×	108 0.6×	27	1.1k

Countries citing papers authored by I.M. Ambros

Since Specialization

Citations

This map shows the geographic impact of I.M. Ambros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.M. Ambros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.M. Ambros more than expected).

Fields of papers citing papers by I.M. Ambros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.M. Ambros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.M. Ambros. The network helps show where I.M. Ambros may publish in the future.

Co-authorship network of co-authors of I.M. Ambros

This figure shows the co-authorship network connecting the top 25 collaborators of I.M. Ambros. A scholar is included among the top collaborators of I.M. Ambros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.M. Ambros. I.M. Ambros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Berbegall, Ana P., Eva Villamón, Marta Piqueras, et al.. (2015). Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors. Oncogene. 35(11). 1423–1432. 21 indexed citations

Schleiermacher, Gudrun, Véronique Mosseri, W. B. London, et al.. (2012). Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. British Journal of Cancer. 107(8). 1418–1422. 129 indexed citations

Ambros, I.M., et al.. (2006). Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyurea. Genes Chromosomes and Cancer. 46(2). 130–142. 30 indexed citations

Preusser, Matthias, P. Birner, I.M. Ambros, et al.. (2005). DEC1 expression in 1p-aberrant oligodendroglial neoplasms.. PubMed. 20(4). 1173–7. 14 indexed citations

Ambros, Peter F., I.M. Ambros, Reinhold Kerbl, et al.. (2001). Intratumoural heterogeneity of 1p deletions andMYCN amplification in neuroblastomas. Medical and Pediatric Oncology. 36(1). 1–4. 52 indexed citations

Ambros, Peter F., I.M. Ambros, Reinhold Kerbl, et al.. (2001). Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Medical and Pediatric Oncology. 36(1). 1–4. 1 indexed citations

Hattinger, Claudia Maria, S. Rumpler, Sabine Strehl, et al.. (1999). Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors. Genes Chromosomes and Cancer. 24(3). 243–254. 65 indexed citations

Shimada, Hiroyuki, I.M. Ambros, Louis P. Dehner, et al.. (1999). Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.. PubMed. 86(2). 349–63. 446 indexed citations

Ambros, I.M., S. Rumpler, A. Luegmayr, et al.. (1997). Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation—sign of tumour cell revertance?. European Journal of Cancer. 33(12). 2043–2049. 54 indexed citations

10.

Cheung, Nai‐Kong V., Brian H. Kushner, Michael P. LaQuaglia, et al.. (1997). Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers. European Journal of Cancer. 33(12). 2117–2120. 19 indexed citations

11.

Kager, Leo, Gabriele Amann, A. Zoubek, et al.. (1997). Pleuropulmonales Blastom. Monatsschrift Kinderheilkunde. 145(5). 510–514.

12.

Kerbl, Reinhold, Christian Urban, Peter F. Ambros, et al.. (1996). Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115 000 screened infants in Austria. European Journal of Cancer. 32(13). 2298–2305. 11 indexed citations

13.

Kushner, Brian H., N K Cheung, Michael P. LaQuaglia, et al.. (1996). International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.. Journal of Clinical Oncology. 14(7). 2174–2180. 36 indexed citations

14.

Kushner, Brian H., Nai‐Kong V. Cheung, Michael P. LaQuaglia, et al.. (1996). Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.. Journal of Clinical Oncology. 14(2). 373–381. 82 indexed citations

15.

Ladenstein, Ruth, Christian Urban, Helmut Gadner, et al.. (1995). First experience with prognostic factors in unselected neuroblastoma patients. The Austrian neuroblastoma 87 study. European Journal of Cancer. 31(4). 637–641. 19 indexed citations

16.

Ambros, I.M. & Peter F. Ambros. (1995). Schwann cells in neuroblastoma. European Journal of Cancer. 31(4). 429–434. 25 indexed citations

17.

Kovar, Heinrich, Michael Dworzak, Sabine Strehl, et al.. (1990). Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor.. PubMed. 5(7). 1067–70. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact